Two Biotechs Fail to IPO: GM’s Offering Dwarfs All Others in Busy Deal Week
Seeking Alpha
Sun, 11/21/10 - 01:43 pm
Anacor
Zogenix
Pharma becomes target for organised crime
Financial Times, UK
Sun, 11/21/10 - 01:40 pm
Roche Open to Small, Medium-Sized Deals, SonntagsZeitung Says
Bloomberg
Sun, 11/21/10 - 01:39 pm
Roche
M&A
Do-It-Yourself Drug Injections May Let CSL Top Baxter in $5 Billion Market
Bloomberg
Sun, 11/21/10 - 01:38 pm
Hizentra
CSL
Baxter International
Alnylam Caught Off-Guard by Roche Decision to Drop Alliance
Seeking Alpha
Sun, 11/21/10 - 01:36 pm
Alnylam
Roche
gene silencing
Biotech Sector Weekly Rewind
The Street
Sat, 11/20/10 - 01:37 pm
biotech
VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study
MarketWatch
Sat, 11/20/10 - 01:35 pm
Vytorin
Merck
chronic kidney disease
Dr Reddy's launches anti-asthma tablets in US
Sify, India
Sat, 11/20/10 - 01:19 pm
Dr Reddy's
Zafirlukast
asthma
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Medical News Today
Sat, 11/20/10 - 01:17 pm
Aeterna Zentaris
AEZS-129
AEZS-132
cancer
melanoma
lung cancer
prostate cancer
colon cancer
breast cancer
endometrial cancer
Cardinal Health to buy pharmaceutical distributor Kinray for $1.3 billion
Pharmabiz
Sat, 11/20/10 - 12:53 pm
Cardinal Health
Kinray
Clarus Therapeutics Files To Sell Up To $86.3M In Shares In IPO
WSJ
Sat, 11/20/10 - 12:47 pm
Clarus Therapeutics
OriTex
testosterone
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Sat, 11/20/10 - 12:46 pm
Helix BioPharma
topical interferon Alpha-2b
cervical lesions
cervical cancer
Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial
Yahoo/BusinessWire
Sat, 11/20/10 - 12:41 pm
Merck
Fosamax
lawsuits
Why Brazil’s Pharmerging Market Can’t Be Ignored
Seeking Alpha
Sat, 11/20/10 - 12:35 pm
Brazil
Scrutiny of Big Pharma set to intensify (In UK)
Financial Times, UK
Sat, 11/20/10 - 12:34 pm
Big Pharma
Names You Need To Know: Pradaxa and Xarelto
Forbes
Sat, 11/20/10 - 12:24 pm
Boehringer Ingelheim
Bayer
JNJ
Pradaxa
Xarelto
blood thinners
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Sat, 11/20/10 - 12:22 pm
Amgen
Prolia
Xgeva
denosumab
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Sat, 11/20/10 - 12:20 pm
Merck
CETP inhibitors
Anacetrapib
cholesterol
Anavex Announces Private Placement
BusinessWire
Sat, 11/20/10 - 12:17 pm
Anavex
Alzheimer's disease
SIGMACEPTOR
cancer
Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Sat, 11/20/10 - 12:15 pm
Human Genome Sciences
Amgen
United Therapeutics

Pages